Status:
UNKNOWN
Light Therapy to Improve Symptoms in Pregnant Women With Major Depressive Disorder
Lead Sponsor:
Guangzhou Psychiatric Hospital
Collaborating Sponsors:
The Third Affiliated Hospital of Guangzhou Medical University
Conditions:
Major Depressive Disorder
Eligibility:
FEMALE
18-45 years
Phase:
NA
Brief Summary
This study will investigate the effectivenss of bright light therapy(10000 lux white)on pregnant women with major depression disorder.
Detailed Description
Depression during pregnancy is a common and high impact disease.Children who are exposed to maternal depression during pregnancy have a higher risk of adverse birth outcomes, such as low birth weight,...
Eligibility Criteria
Inclusion
- Women; 18\~45 years of age; medically healthy, with normal ocular function; 13\~28 weeks pregnancy; DSM-V diagnosis of major depressive disorder HAMD score ≥18
Exclusion
- DSM-V defined bipolar disorder、schizophrenia、schizoaffective disorder,anxiety disorders; substance Use Disorders; substance use within the last 6 months; suicidal ideation, suicidal attempt, suicide behavior, and attempted suicide; being treated by the light therapy; with antidepressant in recent 2 months; Multiple pregnancy; Any obstetrical care or medications for physical disorders that might confound treatment results; current use of β-adrenergic blockers, melatonin, or St. John's wort; thyroid function test results inconsistent with normal pregnancy
Key Trial Info
Start Date :
June 12 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 30 2021
Estimated Enrollment :
140 Patients enrolled
Trial Details
Trial ID
NCT04447430
Start Date
June 12 2020
End Date
December 30 2021
Last Update
June 25 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Guangzhou Brain Hospital (Guangzhou Huiai Hospital)
Guanzhou, Guangdong, China, 510370